NPI: 1891735312 · CHARLOTTE, NC 28262 · Pediatrics Physician · NPI assigned 06/07/2006
Authorized official WALTON, LEEA controls 20+ related entities in our dataset. Read more
| Authorized Official | WALTON, LEEA (RCS MANAGER) |
| NPI Enumeration Date | 06/07/2006 |
Other providers sharing the same authorized official: WALTON, LEEA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 8,026 | $238K |
| 2019 | 7,519 | $300K |
| 2020 | 9,758 | $340K |
| 2021 | 24,372 | $588K |
| 2022 | 42,049 | $716K |
| 2023 | 41,870 | $581K |
| 2024 | 26,943 | $72K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6,050 | 5,377 | $558K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7,106 | 5,856 | $444K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4,466 | 3,777 | $411K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 8,518 | 7,161 | $383K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3,649 | 3,079 | $354K |
| 99199 | Unlisted special service, procedure or report | 79,041 | 77,999 | $251K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 965 | 809 | $87K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 8,663 | 7,471 | $80K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 636 | 513 | $63K |
| 96127 | 9,924 | 8,125 | $41K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,919 | 1,813 | $38K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1,017 | 988 | $33K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 525 | 418 | $24K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 936 | 749 | $17K |
| 90461 | 4,887 | 4,028 | $9K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 620 | 307 | $8K |
| 96161 | 2,220 | 1,776 | $8K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 433 | 416 | $6K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 73 | 57 | $5K |
| 92552 | 4,198 | 3,565 | $3K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 101 | 81 | $3K |
| 90474 | 115 | 111 | $2K | |
| 96160 | 424 | 340 | $1K | |
| 99215 | Prolong outpt/office vis | 14 | 12 | $1K |
| 99381 | 14 | 14 | $1K | |
| 90651 | 103 | 73 | $839.44 | |
| 90686 | 1,218 | 1,104 | $790.98 | |
| 90670 | 3,284 | 2,815 | $706.47 | |
| 90734 | 114 | 94 | $671.75 | |
| 87807 | 33 | 28 | $447.27 | |
| 99173 | 3,334 | 2,846 | $422.87 | |
| 81003 | 287 | 273 | $193.90 | |
| 90674 | 288 | 232 | $103.37 | |
| 90680 | 1,232 | 1,068 | $97.06 | |
| 90710 | 33 | 24 | $0.00 | |
| 90633 | 575 | 481 | $0.00 | |
| 90648 | 844 | 695 | $0.00 | |
| 90707 | 43 | 39 | $0.00 | |
| 90685 | 41 | 39 | $0.00 | |
| 90700 | 18 | 12 | $0.00 | |
| 90715 | 15 | 12 | $0.00 | |
| 90723 | 365 | 301 | $0.00 | |
| 90744 | 449 | 426 | $0.00 | |
| 90698 | 1,493 | 1,300 | $0.00 | |
| 90716 | 45 | 41 | $0.00 | |
| 99174 | 134 | 106 | $0.00 | |
| 90696 | 17 | 12 | $0.00 | |
| 90743 | 58 | 37 | $0.00 |